These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10882685)

  • 1. Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii.
    Turner NA; Russell AD; Furr JR; Lloyd D
    J Antimicrob Chemother; 2000 Jul; 46(1):27-34. PubMed ID: 10882685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance, biguanide sorption and biguanide-induced pentose leakage during encystment of Acanthamoeba castellanii.
    Turner NA; Russell AD; Furr JR; Lloyd D
    J Appl Microbiol; 2004; 96(6):1287-95. PubMed ID: 15139921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encystation in Acanthamoeba castellanii: development of biocide resistance.
    Lloyd D; Turner NA; Khunkitti W; Hann AC; Furr JR; Russell AD
    J Eukaryot Microbiol; 2001; 48(1):11-6. PubMed ID: 11249185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues.
    Alizadeh H; Silvany RE; Meyer DR; Dougherty JM; McCulley JP
    Cornea; 1997 Jan; 16(1):94-100. PubMed ID: 8985640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility.
    Khunkitti W; Lloyd D; Furr JR; Russell AD
    J Infect; 1998 Jan; 36(1):43-8. PubMed ID: 9515667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions.
    Aksozek A; McClellan K; Howard K; Niederkorn JY; Alizadeh H
    J Parasitol; 2002 Jun; 88(3):621-3. PubMed ID: 12099437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro.
    Tirado-Angel J; Gabriel MM; Wilson LA; Ahearn DG
    Curr Eye Res; 1996 Feb; 15(2):225-8. PubMed ID: 8670733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga.
    Perrine D; Chenu JP; Georges P; Lancelot JC; Saturnino C; Robba M
    Antimicrob Agents Chemother; 1995 Feb; 39(2):339-42. PubMed ID: 7726493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro Evaluation the Efficacy of Some New Plant Extracts and Biocides on the Viability of Acanthamoeba castellanii.
    Abdullah Hamad A
    Protist; 2023 Jun; 174(3):125966. PubMed ID: 37229821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lethal effects of biguanides on cysts and trophozoites of Acanthamoeba castellanii.
    Khunkitti W; Lloyd D; Furr JR; Russell AD
    J Appl Bacteriol; 1996 Jul; 81(1):73-7. PubMed ID: 8675485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of standardized methods for assessing biocidal efficacy of contact lens care solutions against Acanthamoeba trophozoites and cysts.
    Kilvington S; Lam A
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4527-37. PubMed ID: 23745008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Protocol for Testing Multipurpose Contact Lens Solution Efficacy Against Acanthamoeba.
    Fedorko DP; Brocious JM; Adams KD; Hitchins VM; Hampton DL; Eydelman MB
    Eye Contact Lens; 2018 Nov; 44(6):367-371. PubMed ID: 29373390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of biocides on Acanthamoeba castellanii as measured by flow cytometry and plaque assay.
    Khunkitti W; Avery SV; Lloyd D; Furr JR; Russell AD
    J Antimicrob Chemother; 1997 Aug; 40(2):227-33. PubMed ID: 9301988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoebicidal or amoebostatic influence of disinfectants used in health facilities and laboratories on corneal strains of Acanthamoeba.
    Baltaza W; Padzik M; Szaflik JP; Dybicz M; Hendiger E; Chomicz L
    Ann Parasitol; 2017; 63(3):167-172. PubMed ID: 29274209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
    Elder MJ; Kilvington S; Dart JK
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1059-64. PubMed ID: 8125716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing cytotoxicity and efficacy of miltefosine and standard antimicrobial agents against Acanthamoeba trophozoites and cyst forms: An in vitro study.
    Latifi A; Mohebali M; Yasami S; Soleimani M; Rezaian M; Kazemirad E
    Acta Trop; 2023 Nov; 247():107009. PubMed ID: 37643658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biguanide-induced changes in Acanthamoeba castellanii: an electron microscopic study.
    Khunkitti W; Hann AC; Lloyd D; Furr JR; Russell AD
    J Appl Microbiol; 1998 Jan; 84(1):53-62. PubMed ID: 15244057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba.
    Alizadeh H; Neelam S; Cavanagh HD
    Eye Contact Lens; 2009 Jan; 35(1):1-5. PubMed ID: 19125040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.